These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 10594859

  • 1. Alternative medicine use in patients with localized prostate carcinoma treated with curative intent.
    Lippert MC, McClain R, Boyd JC, Theodorescu D.
    Cancer; 1999 Dec 15; 86(12):2642-8. PubMed ID: 10594859
    [Abstract] [Full Text] [Related]

  • 2. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
    Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA.
    J Urol; 2007 Jun 15; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
    [Abstract] [Full Text] [Related]

  • 3. Use of complementary and alternative medicine by patients with localized prostate carcinoma: study at a single institute in Japan.
    Yoshimura K, Ichioka K, Terada N, Terai A, Arai Y.
    Int J Clin Oncol; 2003 Feb 15; 8(1):26-30. PubMed ID: 12601539
    [Abstract] [Full Text] [Related]

  • 4. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor.
    Grossfeld GD, Li YP, Lubeck DP, Broering JM, Mehta SS, Carroll PR.
    J Urol; 2002 Aug 15; 168(2):530-5. PubMed ID: 12131303
    [Abstract] [Full Text] [Related]

  • 5. Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer.
    Efstathiou JA, Skowronski RY, Coen JJ, Grocela JA, Hirsch AE, Zietman AL.
    Int J Radiat Oncol Biol Phys; 2008 Aug 01; 71(5):1302-8. PubMed ID: 18262732
    [Abstract] [Full Text] [Related]

  • 6. Is brachytherapy comparable with radical prostatectomy and external-beam radiation for clinically localized prostate cancer?
    Merrick GS, Butler WM, Lief JH, Dorsey AT.
    Tech Urol; 2001 Mar 01; 7(1):12-9. PubMed ID: 11272667
    [Abstract] [Full Text] [Related]

  • 7. A nationwide charge comparison of the principal treatments for early stage prostate carcinoma.
    Brandeis J, Pashos CL, Henning JM, Litwin MS.
    Cancer; 2000 Oct 15; 89(8):1792-9. PubMed ID: 11042575
    [Abstract] [Full Text] [Related]

  • 8. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM, Porter MP, Soloway MS.
    J Urol; 2008 Nov 15; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [Abstract] [Full Text] [Related]

  • 9. Treatment decision-making strategies and influences in patients with localized prostate carcinoma.
    Gwede CK, Pow-Sang J, Seigne J, Heysek R, Helal M, Shade K, Cantor A, Jacobsen PB.
    Cancer; 2005 Oct 01; 104(7):1381-90. PubMed ID: 16080181
    [Abstract] [Full Text] [Related]

  • 10. The 1999 patterns of care study of radiotherapy in localized prostate carcinoma: a comprehensive survey of prostate brachytherapy in the United States.
    Lee WR, Moughan J, Owen JB, Zelefsky MJ.
    Cancer; 2003 Nov 01; 98(9):1987-94. PubMed ID: 14584083
    [Abstract] [Full Text] [Related]

  • 11. Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer.
    Diefenbach MA, Hamrick N, Uzzo R, Pollack A, Horwitz E, Greenberg R, Engstrom PF.
    J Urol; 2003 Jul 01; 170(1):166-9. PubMed ID: 12796672
    [Abstract] [Full Text] [Related]

  • 12. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T, Ito K, Saitoh J, Noda SE, Harashima K, Sakurai H, Nakayama Y, Yamamoto T, Suzuki K, Nakano T, Niibe H.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):463-71. PubMed ID: 16168838
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer.
    D'Amico AV, Hui-Chen M, Renshaw AA, Sussman B, Roehl KA, Catalona WJ.
    J Urol; 2006 Dec 01; 176(6 Pt 2):S11-5. PubMed ID: 17084157
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A comprehensive and novel predictive modeling technique using detailed pathology factors in men with localized prostate carcinoma.
    Potters L, Purrazzella R, Brustein S, Fearn P, Leibel SA, Kattan MW.
    Cancer; 2002 Oct 01; 95(7):1451-6. PubMed ID: 12237913
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
    Kawakami J, Cowan JE, Elkin EP, Latini DM, DuChane J, Carroll PR, CaPSURE Investigators.
    Cancer; 2006 Apr 15; 106(8):1708-14. PubMed ID: 16544313
    [Abstract] [Full Text] [Related]

  • 19. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era.
    D'Amico AV, Whittington R, Malkowicz SB, Cote K, Loffredo M, Schultz D, Chen MH, Tomaszewski JE, Renshaw AA, Wein A, Richie JP.
    Cancer; 2002 Jul 15; 95(2):281-6. PubMed ID: 12124827
    [Abstract] [Full Text] [Related]

  • 20. Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up.
    Ragde H, Korb LJ, Elgamal AA, Grado GL, Nadir BS.
    Cancer; 2000 Jul 01; 89(1):135-41. PubMed ID: 10897010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.